Get Quotes

Market Menu

INCOME STATEMENTS-Aarey Drugs & Pharmaceuticals Ltd.

You can view the income statements for the last 5 years.

BSE

May 20
40.00 +0.30 (+ 0.76%)
Volume 9787
Prev. Close 39.70
Open Price 41.95
Today's Low / High
39.70
     
41.95
Bid Price(Qty.) 0.00 (0)
Open Pr.(Qty.) 0.00 (0)
52 Wk Low / High
30.20
     
64.40

NSE

May 20
40.00 +0.35 (+ 0.88%)
Volume 36021
Prev. Close 39.65
Open Price 40.15
Today's Low / High
39.60
     
42.30
Bid Price(Qty.) 0.00 (0)
Open Pr.(Qty.) 0.00 (0)
52 Wk Low / High
31.15
     
64.35
ISIN No INE198H01019 Market Cap. ( Rs. in Cr. ) 101.55 P/BV 1.01 Book Value ( Rs. ) 39.73
BSE Code 524412 52 Week High/Low ( Rs. ) 64/31 FV/ML 10/1 P/E(X) 15.59
NSE Code AAREYDRUGSEQ Book Closure 30/09/2019 EPS ( Rs. ) 2.57 Div Yield (%) 0.00
( Rs. in Crs. )
ParticularsMar 21Mar 20Mar 19Mar 18Mar 17
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]348.42300.09354.74349.35395.97
Total Operating Revenues348.42300.09354.74349.35395.97
      
Other Income7.016.694.343.183.34
Total Revenue355.43306.78359.08352.53399.30
      
EXPENSES     
Purchase Of Stock-In Trade339.25285.93347.45346.93386.12
Changes In Inventories Of FG,WIP And Stock-In Trade-1.464.25-6.48-9.56-3.13
Employee Benefit Expenses0.400.400.470.380.34
Finance Costs2.431.792.231.924.33
Depreciation And Amortisation Expenses0.920.891.010.710.64
Other Expenses5.596.285.413.963.03
Total Expenses347.13299.54350.09344.34391.33
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax8.307.248.998.197.98
      
Profit/Loss Before Tax8.307.248.998.197.98
      
Tax Expenses-Continued Operations     
Current Tax1.661.502.252.252.10
Deferred Tax0.12-0.050.19-0.240.41
Total Tax Expenses1.791.452.442.012.50
Profit/Loss After Tax And Before ExtraOrdinary Items6.515.796.546.185.47
      
Profit/Loss From Continuing Operations6.515.796.546.185.47
      
Profit/Loss For The Period6.515.796.546.185.47
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)2.792.482.802.643.03
Diluted EPS (Rs.)2.792.802.802.643.03
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend0.000.000.230.000.00
Equity Dividend Rate (%)0.000.001.000.000.00
ParticularsMar 21
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]348.42
Total Operating Revenues348.42
Other Income7.01
Total Revenue355.43
EXPENSES 
Purchase Of Stock-In Trade339.25
Changes In Inventories Of FG,WIP And Stock-In Trade-1.46
Employee Benefit Expenses0.40
Finance Costs2.43
Depreciation And Amortisation Expenses0.92
Other Expenses5.59
Total Expenses347.13
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax8.30
Profit/Loss Before Tax8.30
Tax Expenses-Continued Operations 
Current Tax1.66
Deferred Tax0.12
Total Tax Expenses1.79
Profit/Loss After Tax And Before ExtraOrdinary Items6.51
Profit/Loss From Continuing Operations6.51
Profit/Loss For The Period6.51
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)2.79
Diluted EPS (Rs.)2.79
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend0.00
Equity Dividend Rate (%)0.00